QCM
DGX icon

Qsemble Capital Management’s Quest Diagnostics DGX Stock Holding History

Qsemble Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6,645
Closed -$1.15M – 481
2025
Q4 		$1.15M Buy
+6,645
New +$1.21M 0.1% 257
2024
Q3 		– Sell
-12,880
Closed -$1.76M – 418
2024
Q2 		$1.76M Buy
+12,880
New +$1.76M 0.33% 106
2024
Q1 		– Sell
-2,663
Closed -$367K – 440
2023
Q4 		$367K Buy
+2,663
New +$350K 0.09% 274
2023
Q3 		– Sell
-2,800
Closed -$394K – 340
2023
Q2 		$394K Buy
+2,800
New +$386K 0.28% 130

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Qsemble Capital Management's DGX Position: Q1 2026 in Review

Qsemble Capital Management sold out of Quest Diagnostics (DGX) in Q1 2026, closing a stake of 6,645 shares — an estimated $1.15M sold.

Qsemble Capital Management first reported a position in DGX in Q2 2023 and held it in 4 quarters. The position peaked at $1.76M in Q2 2024. 1,067 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Qsemble Capital Management reported no remaining Quest Diagnostics position as of Q1 2026 after selling out during the quarter.
  • Qsemble Capital Management sold 6,645 Quest Diagnostics shares in Q1 2026, an estimated $1.15M.
  • Qsemble Capital Management first reported a position in Quest Diagnostics in Q2 2023 and held it in 4 quarters.
  • Qsemble Capital Management's Quest Diagnostics position peaked at $1.76M in Q2 2024.
  • 1,067 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Qsemble Capital Management's 13F filing for Q1 2026, filed 7 May 2026.